Prevotella salivae is a Gram-negative, anaerobic bacterium commonly found in the human oral cavity, where it typically functions as part of the commensal microbiota.
However, emerging evidence suggests that its abundance—whether elevated or diminished—may reflect underlying shifts in oral microbial balance, with potential implications for inflammatory oral and systemic conditions.
Prevotella salivae is a Gram-negative, anaerobic bacterium that belongs to the genus Prevotella, a group of microbes commonly found in the human oral cavity, gut, and vaginal microbiome.
Among its relatives, P. salivae is most frequently identified in human saliva and dental plaque samples.
While it is generally considered a commensal species—coexisting with its host without causing harm—its role within the oral microbiome is complex and influenced by changes in microbial balance.
As part of the normal oral flora, P. salivae contributes to the diverse ecosystem that helps maintain oral health. However, shifts in the abundance of this and other species—known as dysbiosis—can be associated with the onset or progression of oral diseases.
Prevotella species possess a variety of virulence factors that support their survival in inflamed tissues and contribute to disease progression. These include:
These virulence mechanisms contribute to Prevotella spp.'s ability to thrive in inflammatory environments, making them active contributors to chronic infections, particularly periodontal disease.
Although P. salivae testing is not a routine diagnostic tool in general dental practice, its detection is relevant in several contexts:
Studies investigating the composition and function of the oral microbiome often assess P. salivae levels. Its relative abundance can serve as a microbial marker when evaluating shifts associated with oral health or disease.
Changes in the oral microbiota—including elevated Prevotella species—are frequently noted in periodontitis and dental caries.
Although P. salivae is not considered a primary pathogen, its presence may signal broader microbial shifts associated with disease states.
In specialized dental clinics and research settings, microbial analysis of subgingival plaque may include P. salivae as one of several taxa linked to disease progression or severity.
Importantly, P. salivae is not a validated stand-alone diagnostic biomarker. Its detection is better interpreted as part of a broader microbial profile, used adjunctively alongside clinical findings such as gingival inflammation, bleeding on probing, and attachment loss.
In the context of oral microbiome analysis, "high levels" of P. salivae refer to an increased proportion of this species within the total microbial community. Elevated levels have been observed in individuals with:
Multiple studies have identified an increased abundance of Prevotella species, including P. salivae, in subgingival plaque from patients with periodontitis.
While not definitively pathogenic on its own, P. salivae may act synergistically with other bacteria to exacerbate inflammation and tissue breakdown.
High P. salivae levels have also been reported in broader contexts of oral dysbiosis, where microbial balance is disturbed and pro-inflammatory conditions prevail.
One study showed that Prevotella salivae levels were significantly higher in the saliva of inflammatory bowel disease (IBD) patients than in healthy controls.
However, the clinical significance of elevated P. salivae depends heavily on the overall context.
The presence of other keystone pathogens (e.g., Porphyromonas gingivalis), immune status, and host genetics all influence whether a high level contributes to disease or is simply a reflection of microbial variability.
Low levels of P. salivae—defined as a decreased relative abundance in the oral microbial community—are not inherently indicative of optimal oral health. Key considerations include:
Oral health is maintained through a balanced and diverse microbial population. Low P. salivae may coexist with an overgrowth of other harmful bacteria or may reflect an altered ecological state following antibiotic use, poor hygiene, or immune changes.
Healthy individuals can have varying levels of P. salivae based on age, diet, genetics, and environmental exposures. Thus, reduced levels may be entirely physiological in some cases.
Clinicians should avoid overinterpreting low P. salivae levels in isolation. Instead, findings should be contextualized within the broader microbial profile, clinical presentation, and patient history.
Click here to learn about oral microbiome testing and order testing.
Avanzato, V. A., D’Angelo, J., Okolie, J., & Massart, A. (2023). Bacteremia With Oral Prevotella Salivae in an 18-Year-Old After a Water Skiing Fall Into a Freshwater Lake. Journal of Investigative Medicine High Impact Case Reports, 11. https://doi.org/10.1177/23247096231159796
Hammad MI, Conrads G, Abdelbary MMH. Isolation, identification, and significance of salivary Veillonella spp., Prevotella spp., and Prevotella salivae in patients with inflammatory bowel disease. Front Cell Infect Microbiol. 2023 Nov 20;13:1278582. doi: 10.3389/fcimb.2023.1278582. PMID: 38053528; PMCID: PMC10694262.
Könönen E, Fteita D, Gursoy UK, Gursoy M. Prevotella species as oral residents and infectious agents with potential impact on systemic conditions. J Oral Microbiol. 2022 May 26;14(1):2079814. doi: 10.1080/20002297.2022.2079814. PMID: 36393976; PMCID: PMC9662046.
Könönen E, Gursoy UK. Oral Prevotella Species and Their Connection to Events of Clinical Relevance in Gastrointestinal and Respiratory Tracts. Front Microbiol. 2022 Jan 6;12:798763. doi: 10.3389/fmicb.2021.798763. PMID: 35069501; PMCID: PMC8770924.
Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017 Aug;151(4):363-374. doi: 10.1111/imm.12760. Epub 2017 Jun 20. PMID: 28542929; PMCID: PMC5506432.
Sharma, G., Garg, N., Hasan, S., & Shirodkar, S. (2022). Prevotella: An insight into its characteristics and associated virulence factors. Microbial Pathogenesis, 169, 105673. https://doi.org/10.1016/j.micpath.2022.105673